Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in early stages of canine osteoarthritis

Veterinarni Medicina

Volumn 53, Issue 4, 2008, Pages 214-220

  Lee, H B ^a   Alam, M R ^b   Seol, J W ^a   Kim, Nam Soo ^a  

^a Chonbuk National University   (South Korea)

^b BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

Author keywords

Matrix metalloproteinase 2; Osteoarthritis; Synovial fluid; Tartrate resistant acid phosphatase; Tissue inhibitor of matrix metalloproteinase 2

Indexed keywords

CANIS FAMILIARIS;

EID: 43249102985     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/1921-vetmed     Document Type: Article

References (21)

1. Adamopoulos I.E., Danks L., Itonaga I., Locklin R.M., Sabokbar A., Ferguson D.J., Athanasou N.A. (2006): Stimulation of osteoclast formation by inflammatory synovial fluid. Virchows Archiv, 449, 69-77
2. Adamopoulos I.E., Sabokbar A., Wordsworth B.P., Carr A., Ferguson D.J., Athanasou N.A. (2006): Synovial fluid macrophages are capable of osteoclast formation and resorption. The Journal of Pathology 208, 35-43
3. Budsberg S.C., Lenz M.E., Thonar E.J. (2006): Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection. American Journal of Veterinary Research 67, 429-432
4. Burrage P.S., Mix K.S., Brinckerhoff C.E. (2006): Matrix metalloproteinases: role in arthritis. Frontiers in Bioscience, 11, 529-543
5. Fox D.B., Cook J.L. (2001): Synovial fluid markers of osteoarthritis in dogs. Journal of the American Veterinary Medical Association 219, 756-761
6. Halleen J.M., Tiitinen S.L., Ylipahkala H., Fagerlund K. M., Vaananen H.K. (2006): Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clinical Laboratory, 52, 499-509
7. Hegemann N., Kohn B., Brunnberg L., Schmidt M.F. (2002): Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis and artilage/OARS, Osteoarthritis Research Society, 10, 714-721
8. Hegemann N., Wondimu A., Ullrich K., Schmidt M.F. (2003): Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Veterinary Immunology and Immunopathology, 91, 199-204
9. Henrotin Y., Sanchez C., Balligand M. (2005): Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Veterinary Journal, 170, 113-123
10. Janckila A.J., Neustadt D.H., Nakasato Y.R., Halleen J.M., Hentunen T., Yam L.T. (2002): Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clinica Chimica Acta; International Journal of Clinical Chemistry, 320, 49-58
11. Johnston S.A. (1997): Osteoarthritis: Joint anatomy, physiology, and pathobiology. The Veterinary Clinics of North America, Small Animal Praktice, 27, 699-723
12. Konttinen Y.T., Takagi M., Mandelin J., Lassus J., Salo J., Ainola M., Li T.F., Virtanen I., Liljestrom M., Sakai H., Kobayashi Y., Sorsa T., Lappalainen R., Demulder A., Santavirta S. (2001): Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. Journal of Bone and Mineral Research, 16, 1780-1786
13. Lang P., Schultzber, M., Andersso, G. (2001): Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. The Journal of Histochemistry and Cytochemistry, 49, 379-396
14. Malemud C.J., Goldberg V.M. (1999): Future directions for research and treatment of osteoarthritis. Frontiers in Bioscience, 4, D762-771
15. Malemud C.J., Islam N., Haqqi T.M. (2003): Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells, Tissues, Organs, 174, 34-48
16. Manicourt D.H., Fujimoto N., Obata K., Thonar E.J. (1994): Serum levels of collagenase, stromelysin-1, and TIMP-1. Age-and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis and Rheumatism, 37, 1774-1783
17. Muir P., Schamberger G.M., Manley P.A., Hao Z. (2005): Localization of cathepsin K and tartrate-resistant acid phosphatase in synovium and cranial cruciate ligament in dogs with cruciate disease. Veterinary Surgery, 34, 239-246
18. Pay S., Erdem H., Serdar M., Dinc A., Simsek I., Turan M. (2002): Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behcet's disease and familial Mediterranean fever. Clinical Rheumatology, 21, 511-515
19. Rosemann T., Laux G., Szecsenyi J. (2007): Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. Journal of Orthopaedic Surgery, 2, 12
20. Salinardi B.J., Roush J.K., Schermerhorn T., Mitchell, K.E. (2006): Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs. Veterinary and Comparative Orthopaedics and Traumatology, 19, 49-55
21. Tsuboi H., Matsui Y., Hayashida K., Yamane S., Maeda-Tanimura M., Nampei A., Hashimoto J., Suzuki R., Yoshikawa H., Ochi T. (2003): Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Annals of the Rheumatic Diseases, 62, 196-203